Switching from Rasagiline to Safinamide as an Add-On Therapy Regimen in Patients with Levodopa: A Literature Review

Switching from Rasagiline to Safinamide as an Add-On Therapy Regimen in Patients with Levodopa: A Literature Review

Parkinson’s disease (PD) is a complex disease, and the treatment is focused on the patient’s clinical symptoms. Levodopa continues to be the most effective drug for symptomatic PD treatment. However, chronic levodopa treatment is associated with the development of motor complications in most patient...

Full description

Bibliographic Details
Main Authors: Pilar Sanchez Alonso, Beatriz De La Casa-Fages, Araceli Alonso-Cánovas, Juan Carlos Martínez-Castrillo
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Brain Sciences
Subjects:
Parkinson’s disease
MAO-B inhibitors
safinamide
rasagiline
adjunctive therapy
therapy switch
Online Access:https://www.mdpi.com/2076-3425/13/2/276

Similar Items

Similar Items